Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kalvista Pharmaceuticals Inc
4XC1Current price
9.75 EUR
0 EUR (0.00%)
Last closed
10.45 USD
Company
www.kalvista.com
ISIN
US4834971032
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
561 548 864 USD
Yield for 12 month
+27.44 %
1Y
3Y
5Y
10Y
15Y
4XC1
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts. Address: 55 Cambridge Parkway, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
29.17 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+1 206 000 USD
Current Year
-86 167 000 USD
Last Year
-802 000 USD
Current Quarter
-224 000 USD
Last Quarter
+987 000 USD
Key Figures 4XC1
1 year
3 years
5 years
10 years
EBITDA
-154 720 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-53.94 %
PEG Ratio
–
Return On Equity TTM
-90.84 %
Wall Street Target Price
29.17 USD
Revenue TTM
3 824 000 USD
Book Value
4.01 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
30.7 %
Dividend Yield
–
Gross Profit TTM
-80 276 000 USD
Earnings per share
-3.57 USD
Diluted Eps TTM
-3.57 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 4XC1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4XC1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:14
Payout Ratio
–
Last Split Date
22.11.2016
Dividend Date
22.11.2016
Stock Valuation 4XC1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
76.3323
Price Sales TTM
107.4168
Enterprise Value EBITDA
-3.5261
Price Book MRQ
3.2497
Financials 4XC1
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4XC1
For 52 weeks
7.39 USD
16.88 USD
50 Day MA
11.44 USD
Shares Short Prior Month
6 508 122
200 Day MA
12.38 USD
Short Ratio
13.35
Shares Short
6 810 297
Short Percent
18.14 %
BeatStart